MEDEXUS PHARMACEUTICALS INC (MDP.CA) Stock Analyst Ratings
Canada • Toronto Stock Exchange • TSX:MDP • CA58410Q2036
2.86 CAD
+0.02 (+0.7%)
Last: Jan 29, 2026, 07:00 PM
ChartMill assigns a Buy % Consensus number of 83% to MDP.CA. The Buy consensus is the weighted average rating of the current analysts ratings.
- Analysts have set a mean price target forecast of 6.33. This target is 121.41% above the current price.
- MDP.CA was analyzed by 8 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about MDP.CA.
- In the previous month the buy percentage consensus was at a similar level.
- MDP.CA was analyzed by 8 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-04-06 | RAYMOND JAMES LTD. | Upgrade | Outperform -> Strong Buy |
| 2025-01-06 | STIFEL CANADA | Maintains | Buy -> Buy |
| 2022-11-10 | Raymond James Capital | Upgrade | Outperform |
| 2022-10-07 | Canaccord Capital | Upgrade | Hold |
| 2022-09-22 | Canaccord Capital | Downgrade | |
| 2022-09-20 | Raymond James Capital | Downgrade | Market Perform |
| 2022-08-10 | Stifel Nicolaus Research | Downgrade | |
| 2022-07-26 | Raymond James Capital | Initiate | Outperform |
| 2022-03-02 | Raymond James Capital | Upgrade | Outperform |
| 2022-02-22 | Raymond James Capital | Initiate | Outperform |
| 2022-02-22 | Raymond James Financial | Initiate | Outperform |
| 2021-11-12 | NationalBankFinancial | Downgrade | Underperform |
| 2021-08-18 | Canaccord Genuity | Downgrade | Hold |
| 2021-03-02 | Canaccord Genuity | Upgrade | Hold -> Buy |
| 2021-02-17 | Canaccord Genuity | Upgrade | Speculative Buy |
MEDEXUS PHARMACEUTICALS INC / MDP.CA FAQ
What is the average price target for MEDEXUS PHARMACEUTICALS INC (MDP.CA) stock?
8 analysts have analysed MDP.CA and the average price target is 6.33 CAD. This implies a price increase of 121.42% is expected in the next year compared to the current price of 2.86.
What is the consensus rating for MDP stock?
The consensus rating for MEDEXUS PHARMACEUTICALS INC (MDP.CA) is 82.5 / 100 . This indicates that analysts generally have a positive outlook on the stock.
How many analysts have analysed MEDEXUS PHARMACEUTICALS INC (MDP.CA)?
The number of analysts covering MEDEXUS PHARMACEUTICALS INC (MDP.CA) is 8.